perphosphatemia, hypocalcemia, and end-organ resiscDNA probe, labeled with 35 S, was used, and the hybridization tance to PTH. Resistance to the action of PTH in patients signal was revealed by autoradiography. The density of signal over osteoblasts was quantitated using a semiautomated Lei- with chronic renal failure has been known for many ca image analysis software package.
years [1, 2] . These findings have been confirmed by the Results. The mean density of PTH1R mRNA signal over demonstration of a diminished calcemic response to PTH osteoblasts in renal high-turnover bone was only 36% of that stimulation in both uremic dogs [3] and rats [4] , while found in nonrenal high-turnover bone (P Ͻ 0.05) and 51% of that found in normal bone (P Ͻ 0.05). Osteoblast PTH1R isolated perfused bones of uremic dogs have a blunted mRNA signal in adynamic bone from individuals with diabetes cAMP response to PTH [5] . Furthermore, recent histomellitus was 28% of normal bone (P Ͻ 0.05) and 54% of that morphometric studies of human bone biopsies have found in renal high-turnover bone (P Ͻ 0.05).
shown that serum intact PTH (iPTH) levels several times
Conclusions. These results demonstrate a down-regulation greater than normal are required to maintain parameters of osteoblast PTH1R mRNA in end-stage renal failure in comparison to normal and high-turnover bone from otherwise of bone turnover within the normal range [6-11]. Such healthy individuals, and provide an insight into the mechanisms data have led several authors to conclude that there of "skeletal resistance" to the actions of PTH. must be altered regulation of PTH receptors, resulting in "down-regulation" or "desensitization" [7, 12] [3, 19, 21] Parathyroid hormone acts on target tissues via a specific receptor that recognizes not only PTH but also PTH-related protein (PTHrP), the PTH/PTHrP receptor viduals obtained from the iliac crest at the time of bone grafting (N ϭ 5). (PTH1R) [22] . Receptor regulation may occur at several points, namely transcription, translation, receptor exSources and preparation of bone tissue pression, ligand affinity, and second-messenger/effector Specimens examined were as follows: 13 illiac bone activation [23] . With the cloning of the rat PTH1R biopsies from individuals with ESRF, which showed no [24, 25] , attention has focused on transcriptional regulaevidence of a mineralization defect or aluminum deposition of the receptor in renal failure in rats. Urena et al tion; 2 illiac bone biopsies from patients with Paget's isolated total RNA from bone and kidney of uremic rats disease; 2 healing fracture callus specimens; and 5 samand found a decrease in PTHR1 mRNA compared with ples of normal iliac bone. Bone trephines were split longinormal rats [26] . Other authors have also recently retudinally into two portions. One portion was fixed in ported a down-regulation of PTH1R mRNA in kidney, ethanol and embedded in methylmethacrylate resin. liver, and heart from uremic rats [27] [28] [29] . Although histoFrom these resin blocks, 7 m sections were cut using a morphometric data suggest that human bone cells exhibit LKB macrotome, stained free-floating in toluidine blue, PTH resistance in renal failure [6] [7] [8] [9] [10] , there is no explaand mounted on glass slides. All renal patients received nation for this at the cellular level in vivo. Cloning of 1 g of oral tetracycline 14 and 4 days prior to bone biopsy. the human PTH1R gene [24, 25] and the development For these samples, additional 15 m sections were cut of molecular techniques such as in situ hybridization for examination of tetracycline labeling using ultraviolet (ISH) have made it possible to address questions that epi-illumination microscopy. The criteria for classificaare fundamental in understanding renal bone cell biology tion as either adynamic or high-turnover bone disease in vivo. Therefore, the aim of this study was to investihave been published previously [30] . The second portion gate, using ISH, whether there is down-regulation of the was fixed for 24 hours in 10% (vol/vol) neutral-buffered PTH1R mRNA in human osteoblasts in renal failure as formalin and then decalcified in 20% wt/vol ethylenedicompared with normal osteoblasts and osteoblasts in aminetetraacetic acid (EDTA; pH 7.2) until radiologiother high-turnover bone states.
cally decalcified (10 to 14 days). Following decalcification, the tissue was processed routinely into paraffin wax METHODS and 5 m sections mounted onto silanated slides [31] for ISH. Subjects This study comprised 13 individuals with renal failure
In situ hybridization (8 male and 5 female, mean age of 46.1 years, range 27 Probe. A human cDNA probe (1.8 kb) to PTH1R (a to 63 years). Of these, three individuals were in endgenerous gift from Dr. Schipani, Boston, MA, USA) was stage renal failure (ESRF) and had a trans-iliac bone random prime labeled to a specific activity of approxibiopsy under general anesthetic at the time of Tenckhoff mately 1 ϫ 10 8 cpm/g using 35 S dCTP. For control purcatheter insertion; the remaining 10 individuals were reposes, similarly sized fragments of lambda DNA labeled ceiving continuous ambulatory peritoneal dialysis (mean to the same specific activity were used. duration of 25.5 months, range 1 to 48 months). The
Hybridization. The prehybridization treatments were cause of renal failure in two individuals was unknown.
as detailed previously [32] . Briefly, these included seTwo had autosomal dominant polycystic kidney disease.
quential immersion in 0.2N HCl (20 min), 0.2 ϫ standard Two individuals were recorded as having hypertensive saline citrate (SSC ϭ 0.15 mol/L NaCl and 0.015 mol/L renal disease. One had chronic pyelonephritis, and six sodium citrate, 10 min); g/mL of proteinase K in 50 had diabetic nephropathy. All subjects were taking calmmol/L Tris-HCl, pH 7.5, one hour at 37ЊC; 0.2% (wt/ cium carbonate with meals as a phosphate binder, and vol) glycine in phosphate-buffered saline (PBS); and none were taking aluminum-containing phosphate bind-0.4% (wt/vol) paraformaldehyde in PBS, pH 7.0 (20 ers. No subject had been treated with vitamin D or had min), and freshly prepared 0.25% (vol/vol) acetic anhyundergone parathyroidectomy. None of the females had dride in 0.1 mol/L triethanolamine, pH 8. Following proreceived hormone replacement therapy. Blood sampling teinase treatment, serial sections were reacted with 1 was carried out on the same day as bone biopsy to allow mg/mL of RNAse A in 0.5 ϫ SSC for one hour at 37ЊC. measurement of ionized calcium, serum phosphate, seAll sections were prehybridized for one hour at 37ЊC in rum iPTH, and serum 1,25(OH) 2 D 3 . The study also com-50% formamide, 1 mg/mL of bovine serum albumin, prised individuals with normal renal function with Pag-0.02% (wt/vol) Ficoll, 0.02% (wt/vol) polyvinyl pyrroliet's disease (N ϭ 2, both male, 61 and 58 years old) and done, 0.6 mol/L NaCl, 0.2 mg/mL of sheared salmon healing bone fracture (N ϭ 2, both male, 42 and 47 years sperm DNA, 10 mmol/L Tris (pH 7.4), 0.5 mmol/L old), which comprised the nonrenal high-turnover group EDTA, 10 mmol/L dithiothreitol (DTT), and 10% (wt/ vol) dextran sulfate. Hybridization with heat denatured and specimens of normal bone from age-matched indi-35 S-labeled probe (100 ng/mL prehybridization solution) groups, and data are represented as the mean and 95% CI. Comparisons between histologic groups were carried was carried out at 37ЊC overnight. After hybridization, the tissue sections were washed with a series of highout using the Mann-Whitney U-test. Differences were considered significant at a value of P Ͻ 0.05. In the renal stringency washes: twice for 5 minutes in 0.5 ϫ SSC with 1 mmol/L EDTA and 10 mmol/L DTT; twice for high-and low-turnover groups, Spearman's rank-order correlation was used to investigate the relationship be-5 minutes in 0.5 ϫ SSC with 1 mmol/L EDTA; 15 minutes in 50% formamide, 0.15 mol/L NaCl, 5 mmol/L Tris (pH tween serum iPTH, serum phosphate, ionized calcium, serum 1,25(OH) 2 D 3 , duration of dialysis, and the age of 7.5), and 0.5 mmol/L EDTA; four times for 5 minutes in 0.5 ϫ SSC at 55ЊC, followed by 5 minutes at room subject at the time of bone biopsy and PTH1R mRNA signal. temperature in 0.5 ϫ SSC. Slides were then dehydrated in 70 and 90% ethanol with 0.3 mol/L ammonium acetate and were air dried. Autoradiography was performed with RESULTS Ilford K5 emulsion melted at 40ЊC and was diluted 1:1 Biochemistry with distilled water. The slides were exposed at 4ЊC for 14 days and then developed in Kodak D 19 developer
The mean serum iPTH for the group with hyperparathyroid bone disease (N ϭ 9) was 644 pg/mL (range 180 for five minutes, rinsed, fixed for five minutes, and counterstained with hematoxylin and eosin.
to 1700 pg/mL) and 85 pg/mL (range 30 to 148 pg/mL) for those with diabetes and adynamic bone (N ϭ 4). The Quantitation. Analysis of autoradiographic signal over bone cells was performed using a Quantimet semiautonormal range for serum iPTH was 10 to 65 pg/mL. The mean serum 1,25(OH) 2 D 3 for the hyperparathyroid bone mated image analysis system incorporating software designed in conjunction with Leica Software Systems (Milgroup was 7.8 pg/mL (range 0 to 18 pg/mL) and 5.8 pg/mL (range 3 to 10 pg/mL) for the group with adynamic ton Keynes, UK). Analysis was performed by two investigators (P.M. and J.A.H.). Using t-test and analysis bone and diabetes mellitus. Levels of 1,25(OH) 2 D 3 greater then 20 pg/mL are considered normal. The mean of variance (ANOVA), there was no significant difference between the two observers (P Ͻ 0.05). ISH was serum phosphate for the hyperparathyroid bone group was 2.1 mmol/L (range 1.2 to 3.07 mmol/L), and that performed four times on a series of biopsies, and no significant difference was found between ISH runs (P Ͻ for the diabetic-adynamic bone group was 1.7 mmol/L (range 1.54 to 2.16). The normal range was 0.75 to 1.5 0.05). Signal density (grains per unit area of cell) was analyzed for osteoblasts. For each biopsy, approximately mmol/L. Mean ionized calcium for the hyperparathyroid bone group was 1.24 mmol/L (range 1.01 to 1.41 mmol/L) 10 random high-power fields were examined or as many as possible if less than 10. All osteoblasts within each and for the diabetic-adynamic bone group was 1.2 mmol/L (range 1.12 to 1.22 mmol/L). The normal range high-power field were identified and their area and that portion of that area covered by signal measured in arbiis taken as 1.12 to 1.33 mmol/L. The complete biochemical data are shown in Table 1 . trary pixel units. This represents "Signal Density." Background signal over matrix and noncellular areas of bone Cellular localization of PTHR1 mRNA was measured in two random high-power fields in the same manner. Results were recorded as the mean density PTH1R mRNA hybridization signal was generally greatest over osteoblasts with variation in signal intensity of signal over cells in all fields, minus the background signal.
seen in the different bone states studied (Fig. 1) . In addition, in individual biopsies, some variability in intenBiochemistry. Serum iPTH levels were measured in all renal patients using a commercially available two-site sity of signal was apparent with "plump" osteoblasts in areas of active matrix synthesis most positive. There was immunoradiometric assay (IRMA) for the measurement of PTH (Nichols Institute Diagnostics, San Juan Capisno difference between cortical and trabecular osteoblasts. No signal was seen over flat resting surface cells, trano, CA, USA). Serum levels of 1,25(OH) 2 D 3 were measured using a method previously described [33] . Seand osteocytes were not convincingly positive except in healing fracture callus. This pattern of signal expression rum phosphate was measured by colorimetric assay using a Hitachi 747 Autoanalyzer (Nissei Sangyo Co., Ltd., was seen in all bone studied, although the level of signal differed. Flat elongated fibroblast-like cells in areas of London). Ionized calcium was determined using a Radiometer ICA2 electrode. peritrabecular fibrosis (in the renal bone biopsies) were positive, although much less than osteoblasts. This was Statistical analysis particularly the case when peritrabecular fibrosis was adjacent to trabecular surfaces, which were being acSummary statistics in the form of means and 95% confidence intervals (95% CI) were calculated for tively remodeled. Scattered unidentifiable bone marrow cells were positive. Clearly, the localized hybridization mRNA signal density for normal bone, Paget's disease and healing fracture, and renal high-and low-turnover signal was also seen over actively resorbing osteoclasts in renal hyperparathyroid bone, healing fracture callus, bone from two uremic rats and found a PTH1R mRNA/ 28S ratio of 0.78 in normal animals compared with 0.59 and particularly in Pagetic bone (Fig. 2) . In Pagetic bone, in rats with chronic renal failure illustrating a downthe hybridization signal was often greater over osteoregulation of receptor mRNA in skeletal tissue [26] . In clasts than over osteoblasts. No identifiable osteoclasts this study of osteoblasts in human bone, the mean were seen in normal bone.
PTH1R mRNA signal density in high-turnover renal osQuantitation of PTH1R mRNA expression teodystrophy samples was 3.70 (3.40 to 4.13, 95% CI) and in diabetic-adynamic renal bone was 1.99 (1.27 to PTH1R mRNA expression in osteoblasts was signifi-2.70, 95% CI). By contrast, in the nonrenal high-turnover cantly less in renal high-turnover bone (mean 3.70, 3.40 specimens, the mean signal density was 10.30 (9.72 to to 4.13, 95% CI) than either the fracture and Pagetic 10.87, 95% CI) and in normal bone was 7.24 (6.41 to bone (mean 10.30, 9.72 to 10.87, 95% CI) or normal 8.08, 95% CI). Hence, renal high-turnover osteoblasts bone (mean 7.24, 6.41 to 8.08, 95% CI, P Ͻ 0.05). In in vivo had levels of PTH1R mRNA expression that diabetic-adynamic bone, PTH1R mRNA expression were 36 and 51% of levels found in nonrenal high-turn-(mean 1.99, 1.27 to 2.70, 95% CI) was significantly less over and normal bone, respectively. Osteoblasts from than in high-turnover renal bone and normal bone (P Ͻ diabetic-adynamic bone had receptor mRNA expression 0.05; Fig. 3 ). There were no significant correlations be-28% of normal osteoblasts and 54% of the expression tween PTH1R mRNA signal and serum PTH (r s ϭ 0.58), found in high-turnover renal bone. Our data show downserum 1,25(OH) 2 D 3 (r s ϭ 0.24), serum phosphate (r s ϭ regulation of PTH1R mRNA in the PTH target tissue, 0.34), ionized calcium (r s ϭ 0.50), age at time of biopsy bone. The decrease in PTH1R expression at the level of (r s ϭ Ϫ0.38). or dialysis duration (r s ϭ Ϫ0.26) when the osteoblast may represent the molecular basis for the analyzed using Spearman's rank-order correlation in the resistance of the skeleton to PTH in uremic patients. It 13 ESRF patients examined (Fig. 4) . must be noted that we have shown down-regulation of receptor mRNA and not of the receptor protein itself, DISCUSSION although it is probable that the expression of the receptor Parathyroid hormone has a central role in renal osteoprotein is also down-regulated in uremia. However, this dystrophy, and the cloning of the PTH1R gene has made still remains to be demonstrated. it possible to investigate the possibility of altered recepIn a study of this nature, where the number of bioptor mRNA regulation. Although several authors have sies is small, it is difficult to draw definite conclusions suggested that abnormal regulation of the PTH1R by about the roles of serum PTH, ionized calcium, serum bone cells in patients with ESRF is likely to be important phosphate, serum vitamin D 3 , and uremic factors in the in the pathogenesis of skeletal resistance to PTH found pathogenesis of PTH1R modulation, in particular the in these patients [7, 11] , to our knowledge, this is the down-regulation of receptor mRNA. There is general first time that a reduction in steady-state levels of PTH1R agreement in the literature regarding the negative regumRNA has been demonstrated in human osteoblasts. latory effect of PTH on PTH1R expression and cAMP PTH1R mRNA in vivo has been shown to be downproduction in vitro [34] [35] [36] [37] [38] [39] [40] [41] . More recently, the expresregulated in uremic rat kidney [26, 27] , liver [28] , and sion of PTH1R receptor mRNA in vitro has been examined and found to be reduced in response to PTH stimuheart [29] . Interestingly, Urena et al have also examined . In animals, however, have not been as clear cut. A reduction of increased PTH levels to normal did not improve the our present study, the majority of individuals had serum PTH levels that were elevated above normal, although blunted calcemic response to PTH in azotemic animals (abstract; Bover et al, XIIth International Congress of those individuals with the higher levels were those with high-turnover bone disease and had relatively higher Nephrology, Jerusalem, Israel, June 13-18, 1993, p 453). In addition, Urena et al have shown that thyroparathyrolevels of PTH1R mRNA expression. This would argue against PTH being the cause of receptor mRNA downidectomy does not prevent renal PTH1R mRNA downregulation in uremic rats, suggesting that hyperparathyregulation. The role of 1,25(OH) 2 D 3 in vivo is to improve or abolroidism is not essential for down-regulation to occur [47] . Others have found that selective parathyroidectomy did ish resistance to PTH in uremic individuals [14] [15] [16] [17] [18] . Studies in vitro reveal that the cAMP response of bone cells normalize receptor mRNA levels in uremic rat kidney, liver, and heart [27] [28] [29] . This same group found that from vitamin D-deplete animals to PTH stimulation is In the present study, the duration of peritoneal dialysis was significantly different between the high-and low-D. No significant correlation was found between serum 1,25(OH) 2 D 3 and receptor mRNA signal in the group of turnover bone groups, with the adynamic group being on dialysis for longer (P Ͻ 0.05). Other studies have individuals examined in this study.
In vivo studies carried out in animals with renal failure indicated that continuous ambulatory peritoneal dialysis is associated with adynamic bone disease [57] , and in have implicated hyperphosphatemia as an important factor in the development of PTH resistance [13, 52] . In our study, adynamic bone is associated with lower levels of receptor mRNA. It must be noted that all of those addition, in vitro experiments have shown that both high [12, 53, 54] and low [55] extracellular levels of phosphate individuals with adynamic bone had diabetes mellitus, which is itself associated with adynamic bone disease, reduce either cAMP or calcium efflux from bone in response to PTH stimulation. No significant correlation and diabetes mellitus has also been shown to be associated with the down-regulation of the PTH1R mRNA was found between serum phosphate and receptor mRNA signal in the group of individuals examined in in renal tissue [56] . Thus, it remains unclear whether duration of dialysis, the presence of diabetes mellitus, our study. In conclusion, our data show that there is a reduction 
